Navigation Links
Sangamo Announces Pricing of Public Offering of Common Stock
Date:10/7/2009

RICHMOND, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions. In addition, Sangamo has granted the underwriter a 30-day option to purchase up to an additional 450,000 shares of common stock to cover over-allotments, if any.

Jefferies & Company, Inc. is acting as sole book-running manager in this offering.

A registration statement relating to the shares of common stock issued in the offering has been filed with, and declared effective by, the Securities and Exchange Commission (the "SEC")." A prospectus supplement relating to the offering will be filed with the SEC. Copies of the prospectus supplement relating to this offering, when available, may be obtained from Jefferies & Company, Inc., Attention: Syndicate Prospectus Department, 520 Madison Avenue, New York, NY, 10022 or at (888) 449-2342. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic((TM)) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Sangamo also has two Phase 1 clinical trials to evaluate safety an
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
2. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
3. Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells
4. Sangamo BioSciences Reports Second Quarter 2009 Financial Results
5. Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
6. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
7. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
8. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
9. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
10. Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results
11. Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... CORALVILLE, Iowa, Dec. 10 Vivakor, ... that it has entered into an exclusive, ... specialist, Regeneca International, Inc. ( www.regeneca.com ). ... distribution rights to a new cutting-edge nutraceutical ... the development of future formulations by Vivakor ...
(Date:12/10/2009)... Biomatrica, the leader in room temperature ... SampleWare 3.1 software system for laboratory inventory, organization ... now includes an audit trail functionality that tracks ... complete history of any stored sample. ,, ... customers a much needed ability to track all ...
(Date:12/10/2009)... SEATTLE, Dec. 10 Dendreon Corporation (Nasdaq: ... the Company as chief operating officer, effective January 4, ... of the specialty medicine business at Bayer, where he ... and neurology products. Mr. Bishop also served as ... ,, As a member of the Dendreon executive management ...
(Date:12/10/2009)... Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) ... company,s Board of Directors. Mr. Farmer, a graduate ... on six other corporate boards. ,, Mr. ... campaigns, including those of John Kerry, Bill Clinton, Michael ... led fundraising of over $800 million. He served ...
Breaking Biology Technology:Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Biomatrica Launches SampleWare 3.1 2Biomatrica Launches SampleWare 3.1 3Dendreon Appoints Hans Bishop as Chief Operating Officer 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3
... ST. LOUIS, Sept. 12 Prolog Ventures, a ... announced that Dan,Broderick has joined the firm as ... of experience in early-stage investing, venture fund,management, and ... was a managing director at Mason,Wells in Milwaukee, ...
... HOST CONFERENCE CALL AT 10:00AM EDT, EDMONTON, ... BIOM ) (TSX: BRA) (the "Company") today ... a proposal to change its,jurisdiction of incorporation from ... Delaware in the United States of America through ...
... Sept. 12 Genstruct Inc., a,biotechnology company translating ... therapeutics, announced today that its president and,CEO, Dr. ... at the Oncology,Clinical Trial Summit in Arlington, Va., ... a panel discussion focused on,"Enhancing Development and Commercial ...
Other Biology Technology:Dan Broderick Joins Prolog Ventures as Partner 2Dan Broderick Joins Prolog Ventures as Partner 3Biomira Announces Plan to Reincorporate in the United States 2Biomira Announces Plan to Reincorporate in the United States 3Biomira Announces Plan to Reincorporate in the United States 4Biomira Announces Plan to Reincorporate in the United States 5Biomira Announces Plan to Reincorporate in the United States 6Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit 2
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... have discovered five genetic variants that are associated with ... an international consortium of 96 scientists from 63 centres ... molecular basis of lung diseases. , The new findings ... Chronic Obstructive Pulmonary Disease (COPD) and asthma. In the ... because the molecular pathways that affect the health of ...
(Date:12/11/2009)... understand that green plants photosynthesize, absorb carbon dioxide ... global-scale effects that photosynthesis has had on Earth. ... origins and evolution of photosynthesis is Jeffrey Touchman, ... Life Sciences. , Oxygen, one of the by-products ... their descendants (including algae and higher plants), transformed ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New genes for lung disease discovered 2'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Want to attract the opposite sex 3F Its in the Smile 51639 1Want to attract the opposite sex 3F Its in the Smile 51639 2Nick Jonas Opens Up About His Diabetes In Exclusive TV Interview July 19th 2009 on dLife 51637 1Nick Jonas Opens Up About His Diabetes In Exclusive TV Interview July 19th 2009 on dLife 51637 2Encompass Group to Offer the Liftaem 28TM 29 Lateral Patient Transfer System 51635 1Encompass Group to Offer the Liftaem 28TM 29 Lateral Patient Transfer System 51635 2
... Michigan's,Comprehensive Cancer Center and the National Cancer Institute ... of skin cancer.,Andrzej Dlugosz, M.D., a professor of ... the University of Michigan and the National,Cancer Institute ... in basal cell carcinoma ?the most common form ...
... researchers at UT Southwestern Medical Center challenge one of ... one another. , Every time we move, feel emotions, ... our body transmit messages to one another via chemical ... synaptic vesicles that sequester neurotransmitters and release them when ...
... How nature wraps and tags genes determines if and when ... Massachusetts Institute of Technology (M.I.T.). They did the largest, most ... the human genome. , Their findings reveal surprising and previously ... of the human body and in diseases such as cancer. ...
Other Biology News:U-M scientists find genes that control growth of common skin cancer 2U-M scientists find genes that control growth of common skin cancer 3New research questions basic tenet of neuron function 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 3
... Strain Competent Cell Sets Sets of ... combinations The most common method ... coli is to use chemically competent ... in the laboratory, greater efficiency, reproducibility and ...
... The BD Pathway Bioimager is an automated, ... imaging system that has been integrated into ... Pathway was designed to provide high-resolution, automated ... assist in developing better cell-based assays. The ...
... Imager delivers high resolution CCD confocal imaging ... effective optical package that fits on your ... combined with high quantum efficiency CCD cameras, ... recording at up to 100 fps. A ...
... Methylation Kit uses a simplified procedure and ... analysis. The kit is based on the ... cytosine and sodium bisulfite where cytosine is ... Kits innovative in-column desulphonation reaction eliminates several ...
Biology Products: